Search articles, concepts, and chapters
9 articles in GJC
Wan Qi, He Peiyuan, Wei Ran, Ma Ke, Yin Hongbo, Tang Jing et al.
V4c ICLs effectively and safely correct high myopia long-term, showing good predictability and stability over five years, making them a viable treatment option.
You Yu X, Chen Chang X, Ma Ke, Jonas Jost B
Zhang Rong, Zhang Haijuan, Xu Liang, Ma Ke, Wallrapp Christine, Jonas Jost B
Zhang Rong, Zhang Haijuan, Xu Liang, Ma Ke, Wallrapp Christine, Jonas Jost B
Intravitreal cell-based GLP-1 production in rats with optic nerve crush significantly increased retinal ganglion cell survival. This suggests GLP-1 could be a neuroprotective strategy for glaucoma.
Zhang Rong, Ma Ke, Xu Liang, Wallrapp Christine, Jonas Jost B
Ma Ke, Xu Liang, Zhang Haijuan, Zhang Shixian, Pu Mingliang, Jonas Jost B
Ginkgo biloba injections in rats with optic nerve crush improved retinal ganglion cell survival. This suggests potential neuroprotection for glaucoma, warranting further investigation.
Ren Ruojin, Jonas Jost B, Tian Guoghong, Zhen Yi, Ma Ke, Li Shuning et al.
This study found that normal-tension glaucoma patients have abnormally low cerebrospinal fluid pressure, increasing the pressure difference across the optic nerve, which correlates with visual field loss.
Ma Ke, Xu Liang, Zhang Haijuan, Zhang Shixian, Pu Mingliang, Jonas Jost B
Brimonidine improved retinal ganglion cell survival in rats after optic nerve crush. This suggests brimonidine may protect RGCs, potentially relevant for glaucoma treatment.
Xu Liang, Li Jianjun, Zheng Yuanyuan, Cui Tongtong, Zhu Jianbo, Ma Ke et al.
This study found average IOP in Northern China is 16 mmHg, peaking around age 55-64, and increasing with myopia. This helps define normal IOP and identify risk factors in this population.
All 9 articles loaded